Status:
COMPLETED
Diabetes Risk Education and Communication Trial
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
PreDiabetes
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A large body of research has demonstrated that intensive lifestyle interventions and metformin are effective treatments to prevent or delay diabetes among high-risk adults, yet neither treatment is ro...
Detailed Description
Landmark clinical trials have found that intensive lifestyle interventions (ILI) and metformin are safe and effective treatment options for preventing diabetes among adults with prediabetes and overwe...
Eligibility Criteria
Inclusion
- Overweight or obesity
- documentation of prediabetes in medical chart or
- A1c 5.7-6.4
Exclusion
- Age \< 18; individuals who are not yet adults (infants, children, teenagers)
- Patient's primary care physician did not provide permission to participate in the study
- Pregnancy status: current or planned pregnancy during study period
- Serum creatinine \>1.4mg/dL in women and \>1.5mg/dL in men
- Patients that are blind, deaf, or otherwise unable to review study materials
- Prior diagnosis of diabetes mellitus type 1 or type 2 or on antidiabetic medication
- Diagnosis of post-surgical hypoinsulinemia
- Diagnosis of dementia
- Uncontrolled hypertension (≥160/100 mm Hg)
- No office visit in past 12 months
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2019
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03283657
Start Date
November 1 2017
End Date
March 17 2019
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611